page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Cefixime (Suprax)

Category:

  • Antibiotic

Description:

  • Cephalosporin, Third Generation

Indications:

  • Uncomplicated urinary tract infections (E. coli and P. mirabilis)

  • Otitis media (H. influenzae, Moraxella catarrhalis, S. pyogenes)

  • Pharyngitis and tonsillitis (S. pyogenes)

  • Acute bronchitis (S. pneumoniae, H. influenzae)

  • Uncomplicated gonorrhea (N. gonorrhoeae)

Contraindications:

  • Cross sensitivity with penicillin allergies

Precautions:

  • Pregnancy category B

  • Use with caution in patients with penicillin allergy (5-10% chance of cross-reactivity)

  • Dosage modifications are generally only required in patients with severe renal impairment

  • Counsel patient to finish all medication to prevent development of resistance

Adverse Reactions (Side Effects):

  • Hypersensitivity reactions

  • Gastrointestinal: nausea, vomiting, diarrhea

  • Vaginitis

Dosage:

  • Administered orally (tablets and suspension)

  • Adults and Children (> 5o kg or > 12 years):

    • 400mg per day as a single dose or 200mg every 12 hours

  • Children

    • 8mg/kg/day as a single dose or 4mg/kg/day every 12 hours

    • For oral suspension: room temperature, shake well, good for 10 days only

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site